REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 1 filers reported holding REGULUS THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $73,000 | 0.0% | 367,739 | 0.0% | 0.00% | -50.0% |
Q3 2018 | $73,000 | -93.4% | 367,739 | -78.2% | 0.00% | -91.7% |
Q2 2018 | $1,110,000 | -12.9% | 1,683,601 | -5.2% | 0.02% | -17.2% |
Q1 2018 | $1,275,000 | -31.0% | 1,776,727 | 0.0% | 0.03% | -29.3% |
Q4 2017 | $1,848,000 | -18.8% | 1,776,727 | -2.4% | 0.04% | -10.9% |
Q3 2017 | $2,275,000 | +73.9% | 1,820,027 | +37.1% | 0.05% | +64.3% |
Q2 2017 | $1,308,000 | -40.3% | 1,327,058 | 0.0% | 0.03% | -37.8% |
Q1 2017 | $2,190,000 | -14.7% | 1,327,058 | +16.3% | 0.04% | -16.7% |
Q4 2016 | $2,567,000 | -13.6% | 1,140,928 | +26.8% | 0.05% | -12.9% |
Q3 2016 | $2,970,000 | +14.2% | 900,000 | 0.0% | 0.06% | +8.8% |
Q2 2016 | $2,601,000 | +195.9% | 900,000 | +609.4% | 0.06% | +200.0% |
Q1 2016 | $879,000 | -46.3% | 126,870 | -32.4% | 0.02% | -47.2% |
Q4 2015 | $1,636,000 | +4.1% | 187,630 | -21.9% | 0.04% | 0.0% |
Q3 2015 | $1,572,000 | -40.3% | 240,330 | 0.0% | 0.04% | -32.1% |
Q2 2015 | $2,634,000 | +119.0% | 240,330 | +238.3% | 0.05% | +130.4% |
Q1 2015 | $1,203,000 | – | 71,033 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Abingworth LLP | 327,350 | $2,943,000 | 1.62% |
HealthCor Management, L.P. | 1,575,000 | $14,207,000 | 0.86% |
Cormorant Asset Management, LP | 200,000 | $1,804,000 | 0.42% |
BVF INC/IL | 184,999 | $1,669,000 | 0.26% |
Verity Asset Management, Inc. | 28,410 | $244,000 | 0.25% |
Callan Capital, LLC | 80,478 | $726,000 | 0.24% |
MARXE AUSTIN W & GREENHOUSE DAVID M | 225,000 | $2,029,000 | 0.22% |
EMERALD MUTUAL FUND ADVISERS TRUST | 61,846 | $558,000 | 0.05% |
LMR Partners LLP | 11,815 | $106,000 | 0.02% |
Weiss Multi-Strategy Advisers LLC | 70,000 | $631,000 | 0.01% |